A Case Report on the Progression of Myeloid Sarcoma to Form Multiple Metastatic Deposits without Developing Acute Myeloid Leukaemia

Por Kohli, Sunita, Lee, Mark, Marshall, Scott
Publicado no Case Rep Hematol (2015)

Handbook of organizational change and innovation /

Por Poole, Marshall Scott., Van de Ven, Andrew H.
Publicado em 2014

Analytical strategies for discovery and replication of genetic effects in pharmacogenomic studies

Por Kohler, Jared R, Guennel, Tobias, Marshall, Scott L
Publicado em 2014

A population pharmacokinetic analysis of sildenafil citrate in patients with erectile dysfunction

Por Milligan, Peter A, Marshall, Scott F, Karlsson, Mats O
Publicado em 2002

Population pharmacokinetics of ampicillin and sulbactam in patients with community-acquired pneumonia: evaluation of the impact of renal impairment

Por Soto, Elena, Shoji, Satoshi, Muto, Chieko, Tomono, Yoshiro, Marshall, Scott
Publicado no Br J Clin Pharmacol (2014)

Population pharmacokinetics of tanezumab in phase 3 clinical trials for osteoarthritis pain

Por Jonsson, E. Niclas, Xie, Rujia, Marshall, Scott F., Arends, Rosalin H.
Publicado no Br J Clin Pharmacol (2016)

Population Pharmacokinetic Model of the Pregabalin-Sildenafil Interaction in Rats: Application of Simulation to Preclinical PK-PD Study Design

Por Bender, Gregor, Gosset, James, Florian, Jeff, Tan, Keith, Field, Mark, Marshall, Scott, DeJongh, Joost, Bies, Robert, Danhof, Meindert
Publicado em 2009

An Empirical Approach to Sufficient Similarity: Combining Exposure Data and Mixtures Toxicology Data

Por Marshall, Scott, Gennings, Chris, Teuschler, Linda K., Stork, LeAnna G., Tornero-Velez, Rogelio, Crofton, Kevin M., Rice, Glenn E.
Publicado em 2013

The acute management of haemorrhage, surgery and overdose in patients receiving dabigatran

Por Alikhan, Raza, Rayment, Rachel, Keeling, David, Baglin, Trevor, Benson, Gary, Green, Laura, Marshall, Scott, Patel, Raj, Pavord, Sue, Rose, Peter, Tait, Campbell
Publicado em 2014

PARP1 expression, activity and ex vivo sensitivity to the PARP inhibitor, talazoparib (BMN 673), in chronic lymphocytic leukaemia

Por Herriott, Ashleigh, Tudhope, Susan J., Junge, Gesa, Rodrigues, Natalie, Patterson, Miranda J., Woodhouse, Laura, Lunec, John, Hunter, Jill E., Mulligan, Evan A., Cole, Michael, Allinson, Lisa M., Wallis, Jonathan P., Marshall, Scott, Wang, Evelyn, Curtin, Nicola J., Willmore, Elaine
Publicado no Oncotarget (2015)

Linkage of cystic fibrosis locus and polymorphic DNA markers in 14 families

Por Naylor, Susan L., Barnett, Don R., Buchanan, James M., Latimer, Jo, Wieder, Ken, Marshall, Scott, Gardner, Julie, Denning, Carolyn R., Gluckson, Muriel, Pinero, Ricardo, Rendon, Henry, Miranda, L. Ivon, Kammerer, Candace, Zansky, Shelley M., King, Rose H., Bowman, Barbara H., MacCluer, Jean W.
Publicado em 1986

The Translational Medicine Ontology and Knowledge Base: driving personalized medicine by bridging the gap between bench and bedside

Por Luciano, Joanne S, Andersson, Bosse, Batchelor, Colin, Bodenreider, Olivier, Clark, Tim, Denney, Christine K, Domarew, Christopher, Gambet, Thomas, Harland, Lee, Jentzsch, Anja, Kashyap, Vipul, Kos, Peter, Kozlovsky, Julia, Lebo, Timothy, Marshall, Scott M, McCusker, Jamie P, McGuinness, Deborah L, Ogbuji, Chimezie, Pichler, Elgar, Powers, Robert L, Prud’hommeaux, Eric, Samwald, Matthias, Schriml, Lynn, Tonellato, Peter J, Whetzel, Patricia L, Zhao, Jun, Stephens, Susie, Dumontier, Michel
Publicado em 2011